Current:Home > reviewsUS regulators might change how they classify marijuana. Here’s what that would mean -ProfitPioneers Hub
US regulators might change how they classify marijuana. Here’s what that would mean
View
Date:2025-04-18 16:32:01
NEW YORK (AP) — The news lit up the world of weed: U.S. health regulators are suggesting that the federal government loosen restrictions on marijuana.
Specifically, the federal Health and Human Services Department has recommended taking marijuana out of a category of drugs deemed to have “no currently accepted medical use and a high potential for abuse.” The agency advised moving pot from that “Schedule I” group to the less tightly regulated “Schedule III.”
So what does that mean, and what are the implications? Read on.
FIRST OF ALL, WHAT HAS ACTUALLY CHANGED? WHAT HAPPENS NEXT?
Technically, nothing yet. Any decision on reclassifying — or “rescheduling,” in government lingo — is up to the Drug Enforcement Administration, which says it will take up the issue. The review process is lengthy and involves taking public comment.
Still, the HHS recommendation is “paradigm-shifting, and it’s very exciting,” said Vince Sliwoski, a Portland, Oregon-based cannabis and psychedelics attorney who runs well-known legal blogs on those topics.
“I can’t emphasize enough how big of news it is,” he said.
It came after President Joe Biden asked both HHS and the attorney general, who oversees the DEA, last year to review how marijuana was classified. Schedule I put it on par, legally, with heroin, LSD, quaaludes and ecstasy, among others.
Biden, a Democrat, supports legalizing medical marijuana for use “where appropriate, consistent with medical and scientific evidence,” White House press secretary Karine Jean-Pierre said Thursday. “That is why it is important for this independent review to go through.”
SO IF MARIJUANA GETS RECLASSIFIED, WOULD IT LEGALIZE RECREATIONAL POT NATIONWIDE?
No. Schedule III drugs — which include ketamine, anabolic steroids and some acetaminophen-codeine combinations — are still controlled substances.
They’re subject to various rules that allow for some medical uses, and for federal criminal prosecution of anyone who traffics in the drugs without permission. (Even under marijuana’s current Schedule I status, federal prosecutions for simply possessing it are few: There were 145 federal sentencings in fiscal year 2021 for that crime, and as of 2022, no defendants were in prison for it.)
It’s unlikely that the medical marijuana programs now licensed in 38 states — to say nothing of the legal recreational pot markets in 23 states — would meet the production, record-keeping, prescribing and other requirements for Schedule III drugs.
But rescheduling in itself would have some impact, particularly on research and on pot business taxes.
WHAT WOULD THIS MEAN FOR RESEARCH?
Because marijuana is on Schedule I, it’s been very difficult to conduct authorized clinical studies that involve administering the drug. That has created something of a Catch-22: calls for more research, but barriers to doing it. (Scientists sometimes rely instead on people’s own reports of their marijuana use.)
Schedule III drugs are easier to study.
In the meantime, a 2022 federal law aimed to ease marijuana research.
WHAT ABOUT TAXES (AND BANKING)?
Under the federal tax code, businesses involved in “trafficking” in marijuana or any other Schedule I or II drug can’t deduct rent, payroll or various other expenses that other businesses can write off. (Yes, at least some cannabis businesses, particularly state-licensed ones, do pay taxes to the federal government, despite its prohibition on marijuana.) Industry groups say the tax rate often ends up at 70% or more.
The deduction rule doesn’t apply to Schedule III drugs, so the proposed change would cut pot companies’ taxes substantially.
They say it would treat them like other industries and help them compete against illegal competitors that are frustrating licensees and officials in places such as New York.
“You’re going to make these state-legal programs stronger,” says Adam Goers, an executive at medical and recreational pot giant Columbia Care. He co-chairs a coalition of corporate and other players that’s pushing for rescheduling.
Rescheduling wouldn’t directly affect another pot business problem: difficulty accessing banks, particularly for loans, because the federally regulated institutions are wary of the drug’s legal status. The industry has been looking instead to a measure called the SAFE Banking Act. It has repeatedly passed the House but stalled in the Senate.
ARE THERE CRITICS? WHAT DO THEY SAY?
Indeed, there are, including the national anti-legalization group Smart Approaches to Marijuana. President Kevin Sabet, a former Obama administration drug policy official, said the HHS recommendation “flies in the face of science, reeks of politics” and gives a regrettable nod to an industry “desperately looking for legitimacy.”
Some legalization advocates say rescheduling weed is too incremental. They want to keep focus on removing it completely from the controlled substances list, which doesn’t include such items as alcohol or tobacco (they’re regulated, but that’s not the same).
National Organization for the Reform of Marijuana Laws Deputy Director Paul Armentano said that simply reclassifying marijuana would be “perpetuating the existing divide between state and federal marijuana policies.” Minority Cannabis Business Association President Kaliko Castille said rescheduling just ”re-brands prohibition,” rather than giving an all-clear to state licensees and putting a definitive close to decades of arrests that disproportionately pulled in people of color.
“Schedule III is going to leave it in this kind of amorphous, mucky middle where people are not going to understand the danger of it still being federally illegal,” he said.
___ Associated Press writer Colleen Long contributed from Washington.
veryGood! (7)
Related
- Where will Elmo go? HBO moves away from 'Sesame Street'
- Family sues Atlanta cop, chief and city after officer used Taser on deacon who later died
- Why Jillian Michaels Is Predicting a Massive Fallout From Ozempic Craze
- Watch this cowboy hurry up and wait in order to rescue a stranded calf on a frozen pond
- Juan Soto to be introduced by Mets at Citi Field after striking record $765 million, 15
- Caffeine in Panera's Charged Lemonade blamed for 'permanent' heart problems in third lawsuit
- The Packers visit the 49ers for record-setting 10th playoff matchup
- Election-year politics threaten Senate border deal as Trump and his allies rally opposition
- Could Bill Belichick, Robert Kraft reunite? Maybe in Pro Football Hall of Fame's 2026 class
- Ex-Florida GOP party chair cleared in sexual assault probe, but could still face voyeurism charges
Ranking
- Scoot flight from Singapore to Wuhan turns back after 'technical issue' detected
- Suspect in killing of TV news anchor’s mother pleads not guilty
- S&P 500 notches first record high in two years in tech-driven run
- Hostage families protest outside Netanyahu’s home, ramping up pressure for a truce-for-hostages deal
- Justice Department, Louisville reach deal after probe prompted by Breonna Taylor killing
- An explosive case of police violence in the Paris suburbs ends with the conviction of 3 officers
- Heat retire Udonis Haslem's No. 40 jersey. He's the 6th Miami player to receive the honor
- The Ravens are ready to give Dalvin Cook a shot, but there’s no telling what to expect
Recommendation
Alex Murdaugh’s murder appeal cites biased clerk and prejudicial evidence
At least 18 dead in a shelling of a market in Russian-occupied Ukraine, officials report
Some 500 migrants depart northern Honduras in a bid to reach the US by caravan
California governor sacks effort to limit tackle football for kids
Selena Gomez engaged to Benny Blanco after 1 year together: 'Forever begins now'
These Are the Best Valentine’s Day Gift Ideas of 2024 for Your Family, Besties, Partner & More
Sports Illustrated to undergo massive layoffs after licensing agreement is revoked
The Challenge's Ashley Cain Welcomes Baby 2 Years After Daughter's Death